nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.284	0.521	CiPCiCtD
Ritonavir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.261	0.479	CiPCiCtD
Ritonavir—CYP2C8—Tazarotene—psoriasis	0.0123	0.0377	CbGbCtD
Ritonavir—CYP3A5—Beclomethasone—psoriasis	0.0119	0.0364	CbGbCtD
Ritonavir—CYP1A2—Clobetasol propionate—psoriasis	0.0117	0.0358	CbGbCtD
Ritonavir—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0108	0.0329	CbGbCtD
Ritonavir—ABCC1—Cyclosporine—psoriasis	0.00969	0.0296	CbGbCtD
Ritonavir—SLCO1A2—Prednisolone—psoriasis	0.00966	0.0296	CbGbCtD
Ritonavir—ABCC2—Mycophenolate mofetil—psoriasis	0.00946	0.0289	CbGbCtD
Ritonavir—SLCO1A2—Hydrocortisone—psoriasis	0.00916	0.028	CbGbCtD
Ritonavir—SLCO1A2—Prednisone—psoriasis	0.00913	0.0279	CbGbCtD
Ritonavir—SLCO1A2—Cyclosporine—psoriasis	0.00865	0.0265	CbGbCtD
Ritonavir—ABCG2—Mycophenolate mofetil—psoriasis	0.00856	0.0262	CbGbCtD
Ritonavir—SLCO1B1—Cyclosporine—psoriasis	0.00816	0.025	CbGbCtD
Ritonavir—ABCC2—Cyclosporine—psoriasis	0.00717	0.0219	CbGbCtD
Ritonavir—CYP2B6—Cholecalciferol—psoriasis	0.00694	0.0212	CbGbCtD
Ritonavir—ABCG2—Hydrocortisone—psoriasis	0.00687	0.021	CbGbCtD
Ritonavir—ABCG2—Cyclosporine—psoriasis	0.00648	0.0198	CbGbCtD
Ritonavir—CYP1A2—Methoxsalen—psoriasis	0.00614	0.0188	CbGbCtD
Ritonavir—SLCO1A2—Dexamethasone—psoriasis	0.0057	0.0174	CbGbCtD
Ritonavir—CYP2D6—Hydroxyurea—psoriasis	0.00553	0.0169	CbGbCtD
Ritonavir—CYP2C8—Cholecalciferol—psoriasis	0.00526	0.0161	CbGbCtD
Ritonavir—ABCC1—Methotrexate—psoriasis	0.00513	0.0157	CbGbCtD
Ritonavir—CYP3A7—Hydrocortisone—psoriasis	0.00507	0.0155	CbGbCtD
Ritonavir—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00507	0.0155	CbGbCtD
Ritonavir—CYP3A7—Cyclosporine—psoriasis	0.00479	0.0146	CbGbCtD
Ritonavir—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00479	0.0146	CbGbCtD
Ritonavir—CYP3A5—Mycophenolate mofetil—psoriasis	0.00474	0.0145	CbGbCtD
Ritonavir—ABCC2—Dexamethasone—psoriasis	0.00472	0.0144	CbGbCtD
Ritonavir—SLCO1A2—Methotrexate—psoriasis	0.00458	0.014	CbGbCtD
Ritonavir—CYP2C8—Mycophenolate mofetil—psoriasis	0.00456	0.0139	CbGbCtD
Ritonavir—CYP2C19—Cholecalciferol—psoriasis	0.00441	0.0135	CbGbCtD
Ritonavir—SLCO1B1—Methotrexate—psoriasis	0.00432	0.0132	CbGbCtD
Ritonavir—ABCG2—Dexamethasone—psoriasis	0.00427	0.0131	CbGbCtD
Ritonavir—CYP3A4—Calcitriol—psoriasis	0.00414	0.0127	CbGbCtD
Ritonavir—CYP3A5—Hydrocortisone—psoriasis	0.0038	0.0116	CbGbCtD
Ritonavir—ABCC2—Methotrexate—psoriasis	0.0038	0.0116	CbGbCtD
Ritonavir—CYP2C9—Cholecalciferol—psoriasis	0.00367	0.0112	CbGbCtD
Ritonavir—CYP2C8—Hydrocortisone—psoriasis	0.00366	0.0112	CbGbCtD
Ritonavir—CYP3A5—Cyclosporine—psoriasis	0.00359	0.011	CbGbCtD
Ritonavir—CYP2C8—Cyclosporine—psoriasis	0.00345	0.0106	CbGbCtD
Ritonavir—ABCG2—Methotrexate—psoriasis	0.00343	0.0105	CbGbCtD
Ritonavir—CYP2D6—Cholecalciferol—psoriasis	0.00335	0.0103	CbGbCtD
Ritonavir—CYP3A4—Methoxsalen—psoriasis	0.00322	0.00984	CbGbCtD
Ritonavir—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00315	0.00965	CbGbCtD
Ritonavir—CYP3A7—Dexamethasone—psoriasis	0.00315	0.00965	CbGbCtD
Ritonavir—ABCB1—Mycophenolate mofetil—psoriasis	0.00309	0.00944	CbGbCtD
Ritonavir—CYP2C19—Prednisone—psoriasis	0.00306	0.00935	CbGbCtD
Ritonavir—CYP2E1—Dexamethasone—psoriasis	0.00304	0.00931	CbGbCtD
Ritonavir—CYP2B6—Dexamethasone—psoriasis	0.003	0.00919	CbGbCtD
Ritonavir—CYP2C19—Cyclosporine—psoriasis	0.0029	0.00886	CbGbCtD
Ritonavir—ABCB1—Betamethasone—psoriasis	0.00265	0.0081	CbGbCtD
Ritonavir—ABCB1—Prednisolone—psoriasis	0.00261	0.00799	CbGbCtD
Ritonavir—ABCB1—Hydrocortisone—psoriasis	0.00248	0.00757	CbGbCtD
Ritonavir—ABCB1—Prednisone—psoriasis	0.00247	0.00754	CbGbCtD
Ritonavir—CYP2C9—Cyclosporine—psoriasis	0.00241	0.00737	CbGbCtD
Ritonavir—CYP3A5—Dexamethasone—psoriasis	0.00237	0.00724	CbGbCtD
Ritonavir—ABCB1—Cyclosporine—psoriasis	0.00234	0.00715	CbGbCtD
Ritonavir—CYP2C8—Dexamethasone—psoriasis	0.00227	0.00696	CbGbCtD
Ritonavir—CYP2D6—Cyclosporine—psoriasis	0.0022	0.00674	CbGbCtD
Ritonavir—CYP3A4—Cholecalciferol—psoriasis	0.00213	0.00652	CbGbCtD
Ritonavir—CYP2C19—Dexamethasone—psoriasis	0.00191	0.00584	CbGbCtD
Ritonavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.00185	0.00565	CbGbCtD
Ritonavir—CYP3A4—Triamcinolone—psoriasis	0.00185	0.00565	CbGbCtD
Ritonavir—CYP2C9—Dexamethasone—psoriasis	0.00159	0.00485	CbGbCtD
Ritonavir—CYP3A4—Betamethasone—psoriasis	0.00159	0.00485	CbGbCtD
Ritonavir—CYP3A4—Prednisolone—psoriasis	0.00156	0.00479	CbGbCtD
Ritonavir—ABCB1—Dexamethasone—psoriasis	0.00154	0.00471	CbGbCtD
Ritonavir—CYP3A4—Hydrocortisone—psoriasis	0.00148	0.00454	CbGbCtD
Ritonavir—CYP3A4—Prednisone—psoriasis	0.00148	0.00452	CbGbCtD
Ritonavir—CYP2D6—Dexamethasone—psoriasis	0.00145	0.00444	CbGbCtD
Ritonavir—CYP3A4—Cyclosporine—psoriasis	0.0014	0.00429	CbGbCtD
Ritonavir—ABCB1—Methotrexate—psoriasis	0.00124	0.00378	CbGbCtD
Ritonavir—CYP3A4—Dexamethasone—psoriasis	0.000922	0.00282	CbGbCtD
Ritonavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000153	0.00953	CbGpPWpGaD
Ritonavir—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000151	0.00942	CbGpPWpGaD
Ritonavir—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000151	0.0094	CbGpPWpGaD
Ritonavir—ABCG2—Iron uptake and transport—CP—psoriasis	0.000142	0.00889	CbGpPWpGaD
Ritonavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000132	0.00825	CbGpPWpGaD
Ritonavir—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00013	0.00815	CbGpPWpGaD
Ritonavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000126	0.0079	CbGpPWpGaD
Ritonavir—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000124	0.00774	CbGpPWpGaD
Ritonavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000124	0.00773	CbGpPWpGaD
Ritonavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000118	0.00737	CbGpPWpGaD
Ritonavir—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000116	0.00727	CbGpPWpGaD
Ritonavir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000112	0.00703	CbGpPWpGaD
Ritonavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000108	0.00678	CbGpPWpGaD
Ritonavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000108	0.00672	CbGpPWpGaD
Ritonavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000107	0.00669	CbGpPWpGaD
Ritonavir—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000107	0.00669	CbGpPWpGaD
Ritonavir—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000106	0.00663	CbGpPWpGaD
Ritonavir—SLC47A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000102	0.00636	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000101	0.00631	CbGpPWpGaD
Ritonavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.56e-05	0.00597	CbGpPWpGaD
Ritonavir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.2e-05	0.00575	CbGpPWpGaD
Ritonavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.19e-05	0.00574	CbGpPWpGaD
Ritonavir—CYP3A7—Biological oxidations—CYP2S1—psoriasis	9.09e-05	0.00568	CbGpPWpGaD
Ritonavir—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.07e-05	0.00567	CbGpPWpGaD
Ritonavir—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	8.96e-05	0.0056	CbGpPWpGaD
Ritonavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	8.79e-05	0.00549	CbGpPWpGaD
Ritonavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	8.72e-05	0.00545	CbGpPWpGaD
Ritonavir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.84e-05	0.0049	CbGpPWpGaD
Ritonavir—ABCC1—S1P1 pathway—VEGFA—psoriasis	7.65e-05	0.00478	CbGpPWpGaD
Ritonavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.45e-05	0.00465	CbGpPWpGaD
Ritonavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.17e-05	0.00448	CbGpPWpGaD
Ritonavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.09e-05	0.00443	CbGpPWpGaD
Ritonavir—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.02e-05	0.00439	CbGpPWpGaD
Ritonavir—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7e-05	0.00437	CbGpPWpGaD
Ritonavir—CYP2B6—Biological oxidations—CYP2S1—psoriasis	6.72e-05	0.0042	CbGpPWpGaD
Ritonavir—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	6.63e-05	0.00414	CbGpPWpGaD
Ritonavir—CYP2E1—Biological oxidations—CYP2S1—psoriasis	6.58e-05	0.00411	CbGpPWpGaD
Ritonavir—CYP3A5—Biological oxidations—CYP2S1—psoriasis	6.57e-05	0.0041	CbGpPWpGaD
Ritonavir—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	6.49e-05	0.00406	CbGpPWpGaD
Ritonavir—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	6.48e-05	0.00405	CbGpPWpGaD
Ritonavir—ABCC2—NRF2 pathway—TGFA—psoriasis	5.87e-05	0.00367	CbGpPWpGaD
Ritonavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.75e-05	0.00359	CbGpPWpGaD
Ritonavir—CYP2C8—Biological oxidations—CYP2S1—psoriasis	5.69e-05	0.00355	CbGpPWpGaD
Ritonavir—CYP2E1—Tryptophan metabolism—CAT—psoriasis	5.68e-05	0.00355	CbGpPWpGaD
Ritonavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	5.67e-05	0.00354	CbGpPWpGaD
Ritonavir—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	5.61e-05	0.00351	CbGpPWpGaD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	5.46e-05	0.00341	CbGpPWpGaD
Ritonavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.29e-05	0.0033	CbGpPWpGaD
Ritonavir—SLC47A1—Transmembrane transport of small molecules—CP—psoriasis	5.17e-05	0.00323	CbGpPWpGaD
Ritonavir—CYP2C19—Biological oxidations—CYP2S1—psoriasis	5.08e-05	0.00317	CbGpPWpGaD
Ritonavir—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	5.01e-05	0.00313	CbGpPWpGaD
Ritonavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5e-05	0.00312	CbGpPWpGaD
Ritonavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.94e-05	0.00309	CbGpPWpGaD
Ritonavir—SLC47A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.93e-05	0.00308	CbGpPWpGaD
Ritonavir—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	4.92e-05	0.00308	CbGpPWpGaD
Ritonavir—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.89e-05	0.00306	CbGpPWpGaD
Ritonavir—CYP2D6—Biological oxidations—CYP2S1—psoriasis	4.67e-05	0.00292	CbGpPWpGaD
Ritonavir—CYP2C9—Biological oxidations—CYP2S1—psoriasis	4.63e-05	0.00289	CbGpPWpGaD
Ritonavir—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	4.61e-05	0.00288	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	4.6e-05	0.00288	CbGpPWpGaD
Ritonavir—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	4.57e-05	0.00285	CbGpPWpGaD
Ritonavir—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	4.53e-05	0.00283	CbGpPWpGaD
Ritonavir—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	4.5e-05	0.00281	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	4.41e-05	0.00275	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.29e-05	0.00268	CbGpPWpGaD
Ritonavir—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	4.26e-05	0.00266	CbGpPWpGaD
Ritonavir—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	4.22e-05	0.00264	CbGpPWpGaD
Ritonavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.22e-05	0.00264	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.21e-05	0.00263	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—IL13—psoriasis	4.19e-05	0.00262	CbGpPWpGaD
Ritonavir—CYP1A2—Biological oxidations—CYP2S1—psoriasis	3.96e-05	0.00247	CbGpPWpGaD
Ritonavir—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	3.9e-05	0.00244	CbGpPWpGaD
Ritonavir—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	3.9e-05	0.00243	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—IL17A—psoriasis	3.85e-05	0.00241	CbGpPWpGaD
Ritonavir—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	3.84e-05	0.0024	CbGpPWpGaD
Ritonavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.69e-05	0.0023	CbGpPWpGaD
Ritonavir—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	3.64e-05	0.00228	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—IL12B—psoriasis	3.58e-05	0.00224	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—HLA-E—psoriasis	3.5e-05	0.00219	CbGpPWpGaD
Ritonavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.44e-05	0.00215	CbGpPWpGaD
Ritonavir—CYP1A2—Tryptophan metabolism—CAT—psoriasis	3.41e-05	0.00213	CbGpPWpGaD
Ritonavir—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	3.27e-05	0.00204	CbGpPWpGaD
Ritonavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.26e-05	0.00204	CbGpPWpGaD
Ritonavir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.05e-05	0.00191	CbGpPWpGaD
Ritonavir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.01e-05	0.00188	CbGpPWpGaD
Ritonavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.94e-05	0.00184	CbGpPWpGaD
Ritonavir—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	2.93e-05	0.00183	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.89e-05	0.00181	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	2.84e-05	0.00178	CbGpPWpGaD
Ritonavir—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	2.69e-05	0.00168	CbGpPWpGaD
Ritonavir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.63e-05	0.00165	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—IL10—psoriasis	2.62e-05	0.00164	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—IL4—psoriasis	2.55e-05	0.00159	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.49e-05	0.00156	CbGpPWpGaD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.49e-05	0.00156	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.48e-05	0.00155	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—NDUFA5—psoriasis	2.33e-05	0.00145	CbGpPWpGaD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.32e-05	0.00145	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.31e-05	0.00144	CbGpPWpGaD
Ritonavir—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	2.28e-05	0.00143	CbGpPWpGaD
Ritonavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.27e-05	0.00142	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.17e-05	0.00136	CbGpPWpGaD
Ritonavir—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	2.16e-05	0.00135	CbGpPWpGaD
Ritonavir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.11e-05	0.00132	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—NDUFA5—psoriasis	2.1e-05	0.00131	CbGpPWpGaD
Ritonavir—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	2.06e-05	0.00129	CbGpPWpGaD
Ritonavir—Body temperature increased—Cyclosporine—psoriasis	2.05e-05	0.000184	CcSEcCtD
Ritonavir—Abdominal pain—Cyclosporine—psoriasis	2.05e-05	0.000184	CcSEcCtD
Ritonavir—Anxiety—Dexamethasone—psoriasis	2.05e-05	0.000183	CcSEcCtD
Ritonavir—Anxiety—Betamethasone—psoriasis	2.05e-05	0.000183	CcSEcCtD
Ritonavir—Vomiting—Mycophenolic acid—psoriasis	2.04e-05	0.000183	CcSEcCtD
Ritonavir—Discomfort—Betamethasone—psoriasis	2.03e-05	0.000182	CcSEcCtD
Ritonavir—Discomfort—Dexamethasone—psoriasis	2.03e-05	0.000182	CcSEcCtD
Ritonavir—Dyspepsia—Hydrocortisone—psoriasis	2.03e-05	0.000182	CcSEcCtD
Ritonavir—Haemoglobin—Methotrexate—psoriasis	2.03e-05	0.000182	CcSEcCtD
Ritonavir—Rash—Mycophenolic acid—psoriasis	2.02e-05	0.000181	CcSEcCtD
Ritonavir—Dermatitis—Mycophenolic acid—psoriasis	2.02e-05	0.000181	CcSEcCtD
Ritonavir—Pain—Prednisolone—psoriasis	2.02e-05	0.000181	CcSEcCtD
Ritonavir—Haemorrhage—Methotrexate—psoriasis	2.02e-05	0.000181	CcSEcCtD
Ritonavir—Hepatitis—Methotrexate—psoriasis	2.02e-05	0.000181	CcSEcCtD
Ritonavir—Urticaria—Mycophenolate mofetil—psoriasis	2.01e-05	0.00018	CcSEcCtD
Ritonavir—Headache—Mycophenolic acid—psoriasis	2.01e-05	0.00018	CcSEcCtD
Ritonavir—Decreased appetite—Hydrocortisone—psoriasis	2e-05	0.00018	CcSEcCtD
Ritonavir—Pharyngitis—Methotrexate—psoriasis	2e-05	0.000179	CcSEcCtD
Ritonavir—Abdominal pain—Mycophenolate mofetil—psoriasis	2e-05	0.000179	CcSEcCtD
Ritonavir—Body temperature increased—Mycophenolate mofetil—psoriasis	2e-05	0.000179	CcSEcCtD
Ritonavir—SLCO1B1—Metabolism—NDUFA5—psoriasis	1.99e-05	0.00124	CbGpPWpGaD
Ritonavir—Urinary tract disorder—Methotrexate—psoriasis	1.99e-05	0.000179	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Hydrocortisone—psoriasis	1.99e-05	0.000178	CcSEcCtD
Ritonavir—Fatigue—Hydrocortisone—psoriasis	1.99e-05	0.000178	CcSEcCtD
Ritonavir—SLCO1A2—Metabolism—CYP2S1—psoriasis	1.98e-05	0.00124	CbGpPWpGaD
Ritonavir—Vision blurred—Prednisone—psoriasis	1.98e-05	0.000177	CcSEcCtD
Ritonavir—Urethral disorder—Methotrexate—psoriasis	1.98e-05	0.000177	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.98e-05	0.000177	CcSEcCtD
Ritonavir—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	1.97e-05	0.00123	CbGpPWpGaD
Ritonavir—Pain—Hydrocortisone—psoriasis	1.97e-05	0.000177	CcSEcCtD
Ritonavir—Oedema—Dexamethasone—psoriasis	1.97e-05	0.000176	CcSEcCtD
Ritonavir—Oedema—Betamethasone—psoriasis	1.97e-05	0.000176	CcSEcCtD
Ritonavir—Insomnia—Triamcinolone—psoriasis	1.96e-05	0.000176	CcSEcCtD
Ritonavir—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.95e-05	0.00122	CbGpPWpGaD
Ritonavir—Ill-defined disorder—Prednisone—psoriasis	1.95e-05	0.000175	CcSEcCtD
Ritonavir—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	1.95e-05	0.00122	CbGpPWpGaD
Ritonavir—Paraesthesia—Triamcinolone—psoriasis	1.95e-05	0.000175	CcSEcCtD
Ritonavir—Feeling abnormal—Prednisolone—psoriasis	1.94e-05	0.000174	CcSEcCtD
Ritonavir—Visual impairment—Methotrexate—psoriasis	1.94e-05	0.000174	CcSEcCtD
Ritonavir—Anaemia—Prednisone—psoriasis	1.94e-05	0.000174	CcSEcCtD
Ritonavir—Shock—Betamethasone—psoriasis	1.94e-05	0.000174	CcSEcCtD
Ritonavir—Shock—Dexamethasone—psoriasis	1.94e-05	0.000174	CcSEcCtD
Ritonavir—Dyspnoea—Triamcinolone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Nervous system disorder—Dexamethasone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Nervous system disorder—Betamethasone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Agitation—Prednisone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Thrombocytopenia—Dexamethasone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Thrombocytopenia—Betamethasone—psoriasis	1.93e-05	0.000173	CcSEcCtD
Ritonavir—Tachycardia—Dexamethasone—psoriasis	1.92e-05	0.000172	CcSEcCtD
Ritonavir—Tachycardia—Betamethasone—psoriasis	1.92e-05	0.000172	CcSEcCtD
Ritonavir—Hypersensitivity—Cyclosporine—psoriasis	1.91e-05	0.000171	CcSEcCtD
Ritonavir—Dyspepsia—Triamcinolone—psoriasis	1.91e-05	0.000171	CcSEcCtD
Ritonavir—Erythema multiforme—Methotrexate—psoriasis	1.91e-05	0.000171	CcSEcCtD
Ritonavir—Nausea—Mycophenolic acid—psoriasis	1.9e-05	0.000171	CcSEcCtD
Ritonavir—Hyperhidrosis—Betamethasone—psoriasis	1.9e-05	0.000171	CcSEcCtD
Ritonavir—Hyperhidrosis—Dexamethasone—psoriasis	1.9e-05	0.000171	CcSEcCtD
Ritonavir—Feeling abnormal—Hydrocortisone—psoriasis	1.9e-05	0.00017	CcSEcCtD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.9e-05	0.00118	CbGpPWpGaD
Ritonavir—Malaise—Prednisone—psoriasis	1.89e-05	0.00017	CcSEcCtD
Ritonavir—Vertigo—Prednisone—psoriasis	1.89e-05	0.000169	CcSEcCtD
Ritonavir—Eye disorder—Methotrexate—psoriasis	1.88e-05	0.000169	CcSEcCtD
Ritonavir—Gastrointestinal pain—Hydrocortisone—psoriasis	1.88e-05	0.000169	CcSEcCtD
Ritonavir—Syncope—Prednisone—psoriasis	1.88e-05	0.000169	CcSEcCtD
Ritonavir—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	1.88e-05	0.00117	CbGpPWpGaD
Ritonavir—Tinnitus—Methotrexate—psoriasis	1.88e-05	0.000169	CcSEcCtD
Ritonavir—Anorexia—Dexamethasone—psoriasis	1.88e-05	0.000168	CcSEcCtD
Ritonavir—Anorexia—Betamethasone—psoriasis	1.88e-05	0.000168	CcSEcCtD
Ritonavir—Urticaria—Prednisolone—psoriasis	1.87e-05	0.000168	CcSEcCtD
Ritonavir—Cardiac disorder—Methotrexate—psoriasis	1.87e-05	0.000168	CcSEcCtD
Ritonavir—Fatigue—Triamcinolone—psoriasis	1.87e-05	0.000168	CcSEcCtD
Ritonavir—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.86e-05	0.000167	CcSEcCtD
Ritonavir—Asthenia—Cyclosporine—psoriasis	1.86e-05	0.000167	CcSEcCtD
Ritonavir—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	1.86e-05	0.00116	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.86e-05	0.00116	CbGpPWpGaD
Ritonavir—Pain—Triamcinolone—psoriasis	1.85e-05	0.000166	CcSEcCtD
Ritonavir—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	1.85e-05	0.00116	CbGpPWpGaD
Ritonavir—Loss of consciousness—Prednisone—psoriasis	1.85e-05	0.000166	CcSEcCtD
Ritonavir—ABCG2—Metabolism—NDUFA5—psoriasis	1.84e-05	0.00115	CbGpPWpGaD
Ritonavir—Hypotension—Dexamethasone—psoriasis	1.84e-05	0.000165	CcSEcCtD
Ritonavir—Hypotension—Betamethasone—psoriasis	1.84e-05	0.000165	CcSEcCtD
Ritonavir—Pruritus—Cyclosporine—psoriasis	1.83e-05	0.000164	CcSEcCtD
Ritonavir—Urticaria—Hydrocortisone—psoriasis	1.83e-05	0.000164	CcSEcCtD
Ritonavir—Angiopathy—Methotrexate—psoriasis	1.83e-05	0.000164	CcSEcCtD
Ritonavir—CYP3A7—Metabolism—NDUFA5—psoriasis	1.83e-05	0.00114	CbGpPWpGaD
Ritonavir—Immune system disorder—Methotrexate—psoriasis	1.82e-05	0.000163	CcSEcCtD
Ritonavir—Abdominal pain—Hydrocortisone—psoriasis	1.82e-05	0.000163	CcSEcCtD
Ritonavir—Body temperature increased—Hydrocortisone—psoriasis	1.82e-05	0.000163	CcSEcCtD
Ritonavir—Convulsion—Prednisone—psoriasis	1.82e-05	0.000163	CcSEcCtD
Ritonavir—Mediastinal disorder—Methotrexate—psoriasis	1.82e-05	0.000163	CcSEcCtD
Ritonavir—Asthenia—Mycophenolate mofetil—psoriasis	1.81e-05	0.000163	CcSEcCtD
Ritonavir—Hypertension—Prednisone—psoriasis	1.81e-05	0.000163	CcSEcCtD
Ritonavir—Chills—Methotrexate—psoriasis	1.81e-05	0.000162	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Betamethasone—psoriasis	1.79e-05	0.000161	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.79e-05	0.000161	CcSEcCtD
Ritonavir—Pruritus—Mycophenolate mofetil—psoriasis	1.79e-05	0.00016	CcSEcCtD
Ritonavir—Myalgia—Prednisone—psoriasis	1.79e-05	0.00016	CcSEcCtD
Ritonavir—Arthralgia—Prednisone—psoriasis	1.79e-05	0.00016	CcSEcCtD
Ritonavir—Feeling abnormal—Triamcinolone—psoriasis	1.79e-05	0.00016	CcSEcCtD
Ritonavir—ABCC1—Metabolism—CYP2S1—psoriasis	1.78e-05	0.00111	CbGpPWpGaD
Ritonavir—Anxiety—Prednisone—psoriasis	1.78e-05	0.00016	CcSEcCtD
Ritonavir—Insomnia—Dexamethasone—psoriasis	1.78e-05	0.00016	CcSEcCtD
Ritonavir—Insomnia—Betamethasone—psoriasis	1.78e-05	0.00016	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.77e-05	0.000159	CcSEcCtD
Ritonavir—Diarrhoea—Cyclosporine—psoriasis	1.77e-05	0.000159	CcSEcCtD
Ritonavir—Paraesthesia—Dexamethasone—psoriasis	1.77e-05	0.000158	CcSEcCtD
Ritonavir—Paraesthesia—Betamethasone—psoriasis	1.77e-05	0.000158	CcSEcCtD
Ritonavir—Discomfort—Prednisone—psoriasis	1.77e-05	0.000158	CcSEcCtD
Ritonavir—Mental disorder—Methotrexate—psoriasis	1.77e-05	0.000158	CcSEcCtD
Ritonavir—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	1.77e-05	0.0011	CbGpPWpGaD
Ritonavir—Malnutrition—Methotrexate—psoriasis	1.75e-05	0.000157	CcSEcCtD
Ritonavir—Hypersensitivity—Prednisolone—psoriasis	1.74e-05	0.000156	CcSEcCtD
Ritonavir—Dyspepsia—Betamethasone—psoriasis	1.73e-05	0.000155	CcSEcCtD
Ritonavir—Dyspepsia—Dexamethasone—psoriasis	1.73e-05	0.000155	CcSEcCtD
Ritonavir—Diarrhoea—Mycophenolate mofetil—psoriasis	1.73e-05	0.000155	CcSEcCtD
Ritonavir—Urticaria—Triamcinolone—psoriasis	1.72e-05	0.000155	CcSEcCtD
Ritonavir—Dysgeusia—Methotrexate—psoriasis	1.72e-05	0.000154	CcSEcCtD
Ritonavir—Body temperature increased—Triamcinolone—psoriasis	1.71e-05	0.000154	CcSEcCtD
Ritonavir—Dizziness—Cyclosporine—psoriasis	1.71e-05	0.000154	CcSEcCtD
Ritonavir—Oedema—Prednisone—psoriasis	1.71e-05	0.000154	CcSEcCtD
Ritonavir—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	1.71e-05	0.00107	CbGpPWpGaD
Ritonavir—Decreased appetite—Betamethasone—psoriasis	1.71e-05	0.000153	CcSEcCtD
Ritonavir—Decreased appetite—Dexamethasone—psoriasis	1.71e-05	0.000153	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Dexamethasone—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Betamethasone—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—Back pain—Methotrexate—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—Hypersensitivity—Hydrocortisone—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—Fatigue—Betamethasone—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—Fatigue—Dexamethasone—psoriasis	1.7e-05	0.000152	CcSEcCtD
Ritonavir—SLCO1B1—Metabolism—CYP2S1—psoriasis	1.69e-05	0.00106	CbGpPWpGaD
Ritonavir—Shock—Prednisone—psoriasis	1.69e-05	0.000151	CcSEcCtD
Ritonavir—Pain—Betamethasone—psoriasis	1.68e-05	0.000151	CcSEcCtD
Ritonavir—Pain—Dexamethasone—psoriasis	1.68e-05	0.000151	CcSEcCtD
Ritonavir—Nervous system disorder—Prednisone—psoriasis	1.68e-05	0.000151	CcSEcCtD
Ritonavir—Tachycardia—Prednisone—psoriasis	1.67e-05	0.00015	CcSEcCtD
Ritonavir—Dizziness—Mycophenolate mofetil—psoriasis	1.67e-05	0.00015	CcSEcCtD
Ritonavir—Skin disorder—Prednisone—psoriasis	1.66e-05	0.000149	CcSEcCtD
Ritonavir—Hyperhidrosis—Prednisone—psoriasis	1.66e-05	0.000149	CcSEcCtD
Ritonavir—Vision blurred—Methotrexate—psoriasis	1.65e-05	0.000148	CcSEcCtD
Ritonavir—Asthenia—Hydrocortisone—psoriasis	1.65e-05	0.000148	CcSEcCtD
Ritonavir—Vomiting—Cyclosporine—psoriasis	1.65e-05	0.000148	CcSEcCtD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.64e-05	0.00102	CbGpPWpGaD
Ritonavir—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.63e-05	0.00102	CbGpPWpGaD
Ritonavir—Rash—Cyclosporine—psoriasis	1.63e-05	0.000147	CcSEcCtD
Ritonavir—Anorexia—Prednisone—psoriasis	1.63e-05	0.000146	CcSEcCtD
Ritonavir—Dermatitis—Cyclosporine—psoriasis	1.63e-05	0.000146	CcSEcCtD
Ritonavir—Pruritus—Hydrocortisone—psoriasis	1.63e-05	0.000146	CcSEcCtD
Ritonavir—Ill-defined disorder—Methotrexate—psoriasis	1.63e-05	0.000146	CcSEcCtD
Ritonavir—Headache—Cyclosporine—psoriasis	1.62e-05	0.000146	CcSEcCtD
Ritonavir—Anaemia—Methotrexate—psoriasis	1.62e-05	0.000145	CcSEcCtD
Ritonavir—Feeling abnormal—Dexamethasone—psoriasis	1.62e-05	0.000145	CcSEcCtD
Ritonavir—Feeling abnormal—Betamethasone—psoriasis	1.62e-05	0.000145	CcSEcCtD
Ritonavir—Gastrointestinal pain—Betamethasone—psoriasis	1.61e-05	0.000144	CcSEcCtD
Ritonavir—Gastrointestinal pain—Dexamethasone—psoriasis	1.61e-05	0.000144	CcSEcCtD
Ritonavir—Vomiting—Mycophenolate mofetil—psoriasis	1.61e-05	0.000144	CcSEcCtD
Ritonavir—Hypersensitivity—Triamcinolone—psoriasis	1.6e-05	0.000143	CcSEcCtD
Ritonavir—Rash—Mycophenolate mofetil—psoriasis	1.59e-05	0.000143	CcSEcCtD
Ritonavir—Dermatitis—Mycophenolate mofetil—psoriasis	1.59e-05	0.000143	CcSEcCtD
Ritonavir—Headache—Mycophenolate mofetil—psoriasis	1.58e-05	0.000142	CcSEcCtD
Ritonavir—Malaise—Methotrexate—psoriasis	1.58e-05	0.000142	CcSEcCtD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.58e-05	0.000986	CbGpPWpGaD
Ritonavir—Vertigo—Methotrexate—psoriasis	1.58e-05	0.000141	CcSEcCtD
Ritonavir—Diarrhoea—Hydrocortisone—psoriasis	1.58e-05	0.000141	CcSEcCtD
Ritonavir—Leukopenia—Methotrexate—psoriasis	1.57e-05	0.000141	CcSEcCtD
Ritonavir—ABCG2—Metabolism—CYP2S1—psoriasis	1.57e-05	0.00098	CbGpPWpGaD
Ritonavir—Urticaria—Dexamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Urticaria—Betamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Prednisone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Dizziness—Prednisolone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Asthenia—Triamcinolone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Body temperature increased—Betamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Abdominal pain—Dexamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Abdominal pain—Betamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—Body temperature increased—Dexamethasone—psoriasis	1.56e-05	0.00014	CcSEcCtD
Ritonavir—CYP3A7—Metabolism—CYP2S1—psoriasis	1.55e-05	0.000971	CbGpPWpGaD
Ritonavir—Insomnia—Prednisone—psoriasis	1.55e-05	0.000139	CcSEcCtD
Ritonavir—ABCB1—Allograft Rejection—IFNG—psoriasis	1.54e-05	0.000963	CbGpPWpGaD
Ritonavir—Nausea—Cyclosporine—psoriasis	1.54e-05	0.000138	CcSEcCtD
Ritonavir—Paraesthesia—Prednisone—psoriasis	1.54e-05	0.000138	CcSEcCtD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.54e-05	0.000961	CbGpPWpGaD
Ritonavir—Pruritus—Triamcinolone—psoriasis	1.53e-05	0.000138	CcSEcCtD
Ritonavir—Cough—Methotrexate—psoriasis	1.53e-05	0.000137	CcSEcCtD
Ritonavir—Dizziness—Hydrocortisone—psoriasis	1.52e-05	0.000137	CcSEcCtD
Ritonavir—Convulsion—Methotrexate—psoriasis	1.52e-05	0.000136	CcSEcCtD
Ritonavir—Dyspepsia—Prednisone—psoriasis	1.51e-05	0.000135	CcSEcCtD
Ritonavir—Nausea—Mycophenolate mofetil—psoriasis	1.5e-05	0.000135	CcSEcCtD
Ritonavir—Arthralgia—Methotrexate—psoriasis	1.49e-05	0.000134	CcSEcCtD
Ritonavir—Myalgia—Methotrexate—psoriasis	1.49e-05	0.000134	CcSEcCtD
Ritonavir—Chest pain—Methotrexate—psoriasis	1.49e-05	0.000134	CcSEcCtD
Ritonavir—Decreased appetite—Prednisone—psoriasis	1.49e-05	0.000134	CcSEcCtD
Ritonavir—Rash—Prednisolone—psoriasis	1.49e-05	0.000133	CcSEcCtD
Ritonavir—Dermatitis—Prednisolone—psoriasis	1.49e-05	0.000133	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.48e-05	0.000133	CcSEcCtD
Ritonavir—Fatigue—Prednisone—psoriasis	1.48e-05	0.000133	CcSEcCtD
Ritonavir—Headache—Prednisolone—psoriasis	1.48e-05	0.000132	CcSEcCtD
Ritonavir—Discomfort—Methotrexate—psoriasis	1.48e-05	0.000132	CcSEcCtD
Ritonavir—Constipation—Prednisone—psoriasis	1.47e-05	0.000131	CcSEcCtD
Ritonavir—Vomiting—Hydrocortisone—psoriasis	1.46e-05	0.000131	CcSEcCtD
Ritonavir—Rash—Hydrocortisone—psoriasis	1.45e-05	0.00013	CcSEcCtD
Ritonavir—Dermatitis—Hydrocortisone—psoriasis	1.45e-05	0.00013	CcSEcCtD
Ritonavir—Confusional state—Methotrexate—psoriasis	1.44e-05	0.00013	CcSEcCtD
Ritonavir—Headache—Hydrocortisone—psoriasis	1.44e-05	0.000129	CcSEcCtD
Ritonavir—Dizziness—Triamcinolone—psoriasis	1.43e-05	0.000129	CcSEcCtD
Ritonavir—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.43e-05	0.000895	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.43e-05	0.000894	CbGpPWpGaD
Ritonavir—Feeling abnormal—Prednisone—psoriasis	1.41e-05	0.000127	CcSEcCtD
Ritonavir—Asthenia—Dexamethasone—psoriasis	1.41e-05	0.000127	CcSEcCtD
Ritonavir—Asthenia—Betamethasone—psoriasis	1.41e-05	0.000127	CcSEcCtD
Ritonavir—Nervous system disorder—Methotrexate—psoriasis	1.4e-05	0.000126	CcSEcCtD
Ritonavir—Thrombocytopenia—Methotrexate—psoriasis	1.4e-05	0.000126	CcSEcCtD
Ritonavir—Gastrointestinal pain—Prednisone—psoriasis	1.4e-05	0.000126	CcSEcCtD
Ritonavir—Nausea—Prednisolone—psoriasis	1.4e-05	0.000126	CcSEcCtD
Ritonavir—Pruritus—Betamethasone—psoriasis	1.39e-05	0.000125	CcSEcCtD
Ritonavir—Pruritus—Dexamethasone—psoriasis	1.39e-05	0.000125	CcSEcCtD
Ritonavir—Skin disorder—Methotrexate—psoriasis	1.39e-05	0.000125	CcSEcCtD
Ritonavir—Hyperhidrosis—Methotrexate—psoriasis	1.38e-05	0.000124	CcSEcCtD
Ritonavir—Vomiting—Triamcinolone—psoriasis	1.38e-05	0.000124	CcSEcCtD
Ritonavir—Nausea—Hydrocortisone—psoriasis	1.37e-05	0.000123	CcSEcCtD
Ritonavir—Rash—Triamcinolone—psoriasis	1.37e-05	0.000123	CcSEcCtD
Ritonavir—Dermatitis—Triamcinolone—psoriasis	1.37e-05	0.000123	CcSEcCtD
Ritonavir—Anorexia—Methotrexate—psoriasis	1.36e-05	0.000122	CcSEcCtD
Ritonavir—Urticaria—Prednisone—psoriasis	1.36e-05	0.000122	CcSEcCtD
Ritonavir—Headache—Triamcinolone—psoriasis	1.36e-05	0.000122	CcSEcCtD
Ritonavir—Abdominal pain—Prednisone—psoriasis	1.35e-05	0.000121	CcSEcCtD
Ritonavir—Body temperature increased—Prednisone—psoriasis	1.35e-05	0.000121	CcSEcCtD
Ritonavir—CYP2B6—Metabolism—NDUFA5—psoriasis	1.35e-05	0.000844	CbGpPWpGaD
Ritonavir—Diarrhoea—Dexamethasone—psoriasis	1.35e-05	0.000121	CcSEcCtD
Ritonavir—Diarrhoea—Betamethasone—psoriasis	1.35e-05	0.000121	CcSEcCtD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.34e-05	0.000839	CbGpPWpGaD
Ritonavir—Hypotension—Methotrexate—psoriasis	1.34e-05	0.00012	CcSEcCtD
Ritonavir—CYP2E1—Metabolism—NDUFA5—psoriasis	1.32e-05	0.000827	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NDUFA5—psoriasis	1.32e-05	0.000825	CbGpPWpGaD
Ritonavir—Musculoskeletal discomfort—Methotrexate—psoriasis	1.3e-05	0.000117	CcSEcCtD
Ritonavir—Dizziness—Betamethasone—psoriasis	1.3e-05	0.000117	CcSEcCtD
Ritonavir—Dizziness—Dexamethasone—psoriasis	1.3e-05	0.000117	CcSEcCtD
Ritonavir—Insomnia—Methotrexate—psoriasis	1.3e-05	0.000116	CcSEcCtD
Ritonavir—Nausea—Triamcinolone—psoriasis	1.29e-05	0.000116	CcSEcCtD
Ritonavir—Paraesthesia—Methotrexate—psoriasis	1.29e-05	0.000115	CcSEcCtD
Ritonavir—Dyspnoea—Methotrexate—psoriasis	1.28e-05	0.000115	CcSEcCtD
Ritonavir—Somnolence—Methotrexate—psoriasis	1.27e-05	0.000114	CcSEcCtD
Ritonavir—Hypersensitivity—Prednisone—psoriasis	1.26e-05	0.000113	CcSEcCtD
Ritonavir—Dyspepsia—Methotrexate—psoriasis	1.26e-05	0.000113	CcSEcCtD
Ritonavir—Vomiting—Dexamethasone—psoriasis	1.25e-05	0.000112	CcSEcCtD
Ritonavir—Vomiting—Betamethasone—psoriasis	1.25e-05	0.000112	CcSEcCtD
Ritonavir—Decreased appetite—Methotrexate—psoriasis	1.24e-05	0.000112	CcSEcCtD
Ritonavir—Rash—Dexamethasone—psoriasis	1.24e-05	0.000111	CcSEcCtD
Ritonavir—Rash—Betamethasone—psoriasis	1.24e-05	0.000111	CcSEcCtD
Ritonavir—Dermatitis—Dexamethasone—psoriasis	1.24e-05	0.000111	CcSEcCtD
Ritonavir—Dermatitis—Betamethasone—psoriasis	1.24e-05	0.000111	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Methotrexate—psoriasis	1.24e-05	0.000111	CcSEcCtD
Ritonavir—Fatigue—Methotrexate—psoriasis	1.23e-05	0.000111	CcSEcCtD
Ritonavir—Headache—Dexamethasone—psoriasis	1.23e-05	0.000111	CcSEcCtD
Ritonavir—Headache—Betamethasone—psoriasis	1.23e-05	0.000111	CcSEcCtD
Ritonavir—Asthenia—Prednisone—psoriasis	1.23e-05	0.00011	CcSEcCtD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.23e-05	0.000767	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.23e-05	0.000767	CbGpPWpGaD
Ritonavir—Pain—Methotrexate—psoriasis	1.22e-05	0.00011	CcSEcCtD
Ritonavir—Pruritus—Prednisone—psoriasis	1.21e-05	0.000109	CcSEcCtD
Ritonavir—Feeling abnormal—Methotrexate—psoriasis	1.18e-05	0.000106	CcSEcCtD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.18e-05	0.000737	CbGpPWpGaD
Ritonavir—Diarrhoea—Prednisone—psoriasis	1.17e-05	0.000105	CcSEcCtD
Ritonavir—Gastrointestinal pain—Methotrexate—psoriasis	1.17e-05	0.000105	CcSEcCtD
Ritonavir—Nausea—Dexamethasone—psoriasis	1.17e-05	0.000105	CcSEcCtD
Ritonavir—Nausea—Betamethasone—psoriasis	1.17e-05	0.000105	CcSEcCtD
Ritonavir—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.16e-05	0.000727	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CYP2S1—psoriasis	1.15e-05	0.000718	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NDUFA5—psoriasis	1.14e-05	0.000715	CbGpPWpGaD
Ritonavir—Urticaria—Methotrexate—psoriasis	1.14e-05	0.000102	CcSEcCtD
Ritonavir—Dizziness—Prednisone—psoriasis	1.13e-05	0.000102	CcSEcCtD
Ritonavir—Body temperature increased—Methotrexate—psoriasis	1.13e-05	0.000102	CcSEcCtD
Ritonavir—Abdominal pain—Methotrexate—psoriasis	1.13e-05	0.000102	CcSEcCtD
Ritonavir—CYP2E1—Metabolism—CYP2S1—psoriasis	1.13e-05	0.000703	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CYP2S1—psoriasis	1.12e-05	0.000702	CbGpPWpGaD
Ritonavir—Vomiting—Prednisone—psoriasis	1.09e-05	9.77e-05	CcSEcCtD
Ritonavir—Rash—Prednisone—psoriasis	1.08e-05	9.69e-05	CcSEcCtD
Ritonavir—Dermatitis—Prednisone—psoriasis	1.08e-05	9.68e-05	CcSEcCtD
Ritonavir—Headache—Prednisone—psoriasis	1.07e-05	9.63e-05	CcSEcCtD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.07e-05	0.000667	CbGpPWpGaD
Ritonavir—Hypersensitivity—Methotrexate—psoriasis	1.05e-05	9.46e-05	CcSEcCtD
Ritonavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.04e-05	0.000648	CbGpPWpGaD
Ritonavir—Asthenia—Methotrexate—psoriasis	1.03e-05	9.22e-05	CcSEcCtD
Ritonavir—CYP2C19—Metabolism—NDUFA5—psoriasis	1.02e-05	0.000638	CbGpPWpGaD
Ritonavir—Nausea—Prednisone—psoriasis	1.02e-05	9.13e-05	CcSEcCtD
Ritonavir—Pruritus—Methotrexate—psoriasis	1.01e-05	9.09e-05	CcSEcCtD
Ritonavir—ABCB1—Allograft Rejection—TNF—psoriasis	9.97e-06	0.000623	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NDUFA5—psoriasis	9.97e-06	0.000623	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	9.91e-06	0.000619	CbGpPWpGaD
Ritonavir—Diarrhoea—Methotrexate—psoriasis	9.8e-06	8.79e-05	CcSEcCtD
Ritonavir—CYP2C8—Metabolism—CYP2S1—psoriasis	9.73e-06	0.000608	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—CARM1—psoriasis	9.67e-06	0.000604	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.52e-06	0.000595	CbGpPWpGaD
Ritonavir—Dizziness—Methotrexate—psoriasis	9.47e-06	8.49e-05	CcSEcCtD
Ritonavir—CYP2D6—Metabolism—NDUFA5—psoriasis	9.39e-06	0.000587	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.34e-06	0.000583	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NDUFA5—psoriasis	9.31e-06	0.000582	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	9.26e-06	0.000579	CbGpPWpGaD
Ritonavir—Vomiting—Methotrexate—psoriasis	9.1e-06	8.17e-05	CcSEcCtD
Ritonavir—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.04e-06	0.000565	CbGpPWpGaD
Ritonavir—Rash—Methotrexate—psoriasis	9.03e-06	8.1e-05	CcSEcCtD
Ritonavir—Dermatitis—Methotrexate—psoriasis	9.02e-06	8.09e-05	CcSEcCtD
Ritonavir—Headache—Methotrexate—psoriasis	8.97e-06	8.05e-05	CcSEcCtD
Ritonavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.87e-06	0.000554	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	8.84e-06	0.000552	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CARM1—psoriasis	8.7e-06	0.000544	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CYP2S1—psoriasis	8.68e-06	0.000543	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.68e-06	0.000543	CbGpPWpGaD
Ritonavir—Nausea—Methotrexate—psoriasis	8.51e-06	7.63e-05	CcSEcCtD
Ritonavir—ABCB1—Metabolism—CYP2S1—psoriasis	8.48e-06	0.00053	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CARM1—psoriasis	8.27e-06	0.000517	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.13e-06	0.000508	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CYP2S1—psoriasis	7.99e-06	0.000499	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NDUFA5—psoriasis	7.96e-06	0.000497	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CYP2S1—psoriasis	7.92e-06	0.000495	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.73e-06	0.000483	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CARM1—psoriasis	7.66e-06	0.000478	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CARM1—psoriasis	7.59e-06	0.000474	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.42e-06	0.000464	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CYP2S1—psoriasis	6.77e-06	0.000423	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.57e-06	0.000411	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.33e-06	0.000395	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NDUFA5—psoriasis	6.14e-06	0.000384	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—CAT—psoriasis	5.95e-06	0.000372	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.74e-06	0.000359	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CARM1—psoriasis	5.61e-06	0.000351	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CARM1—psoriasis	5.5e-06	0.000343	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CARM1—psoriasis	5.49e-06	0.000343	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CAT—psoriasis	5.35e-06	0.000334	CbGpPWpGaD
Ritonavir—ABCC1—Disease—HLA-A—psoriasis	5.32e-06	0.000332	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CYP2S1—psoriasis	5.22e-06	0.000326	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.1e-06	0.000319	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CAT—psoriasis	5.09e-06	0.000318	CbGpPWpGaD
Ritonavir—ABCC1—Disease—APOE—psoriasis	4.96e-06	0.00031	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.92e-06	0.000307	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CARM1—psoriasis	4.75e-06	0.000297	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CAT—psoriasis	4.71e-06	0.000294	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CAT—psoriasis	4.67e-06	0.000292	CbGpPWpGaD
Ritonavir—ABCC1—Disease—NOS2—psoriasis	4.63e-06	0.000289	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—APOE—psoriasis	4.62e-06	0.000289	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.55e-06	0.000284	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.44e-06	0.000277	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.34e-06	0.000271	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CARM1—psoriasis	4.24e-06	0.000265	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—APOE—psoriasis	4.16e-06	0.00026	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.15e-06	0.000259	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CARM1—psoriasis	4.14e-06	0.000259	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PPARG—psoriasis	4.02e-06	0.000251	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.96e-06	0.000248	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—APOE—psoriasis	3.95e-06	0.000247	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CARM1—psoriasis	3.9e-06	0.000244	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CARM1—psoriasis	3.87e-06	0.000242	CbGpPWpGaD
Ritonavir—ABCC1—Disease—TYK2—psoriasis	3.79e-06	0.000237	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—APOE—psoriasis	3.66e-06	0.000229	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—APOE—psoriasis	3.63e-06	0.000227	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PPARG—psoriasis	3.62e-06	0.000226	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.61e-06	0.000226	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.55e-06	0.000222	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CAT—psoriasis	3.45e-06	0.000216	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PPARG—psoriasis	3.44e-06	0.000215	CbGpPWpGaD
Ritonavir—ABCC1—Disease—CD4—psoriasis	3.43e-06	0.000214	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CAT—psoriasis	3.38e-06	0.000211	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CAT—psoriasis	3.37e-06	0.000211	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CARM1—psoriasis	3.3e-06	0.000206	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PPARG—psoriasis	3.19e-06	0.000199	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PPARG—psoriasis	3.16e-06	0.000197	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.09e-06	0.000193	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CAT—psoriasis	2.92e-06	0.000183	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—APOE—psoriasis	2.68e-06	0.000168	CbGpPWpGaD
Ritonavir—ABCC1—Disease—STAT3—psoriasis	2.65e-06	0.000166	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—APOE—psoriasis	2.63e-06	0.000164	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—APOE—psoriasis	2.62e-06	0.000164	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CAT—psoriasis	2.61e-06	0.000163	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CARM1—psoriasis	2.55e-06	0.000159	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CAT—psoriasis	2.55e-06	0.000159	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CAT—psoriasis	2.4e-06	0.00015	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CAT—psoriasis	2.38e-06	0.000149	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PPARG—psoriasis	2.34e-06	0.000146	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PPARG—psoriasis	2.29e-06	0.000143	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PPARG—psoriasis	2.28e-06	0.000143	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—APOE—psoriasis	2.27e-06	0.000142	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CAT—psoriasis	2.03e-06	0.000127	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—APOE—psoriasis	2.03e-06	0.000127	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—APOE—psoriasis	1.98e-06	0.000124	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PPARG—psoriasis	1.98e-06	0.000124	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—APOE—psoriasis	1.86e-06	0.000116	CbGpPWpGaD
Ritonavir—ABCC1—Disease—IL6—psoriasis	1.85e-06	0.000116	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—APOE—psoriasis	1.85e-06	0.000115	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PPARG—psoriasis	1.77e-06	0.00011	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PPARG—psoriasis	1.72e-06	0.000108	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PPARG—psoriasis	1.62e-06	0.000101	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PPARG—psoriasis	1.61e-06	0.000101	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—APOE—psoriasis	1.58e-06	9.87e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CAT—psoriasis	1.57e-06	9.8e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PPARG—psoriasis	1.38e-06	8.59e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—APOE—psoriasis	1.22e-06	7.62e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PPARG—psoriasis	1.06e-06	6.63e-05	CbGpPWpGaD
